136 related articles for article (PubMed ID: 25263008)
1. Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components.
Saxena A; Sampson JR
Semin Cell Dev Biol; 2014 Dec; 36():140-6. PubMed ID: 25263008
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular effects of the mTOR inhibitor everolimus.
Saran U; Foti M; Dufour JF
Clin Sci (Lond); 2015 Nov; 129(10):895-914. PubMed ID: 26330617
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
4. TOR-inhibitors as gero-suppressors.
Nikiforov M
Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
[No Abstract] [Full Text] [Related]
5. mTORC1 inhibitors suppress meningioma growth in mouse models.
Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
[TBL] [Abstract][Full Text] [Related]
6. Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.
Guan Y; Zhang L; Li X; Zhang X; Liu S; Gao N; Li L; Gao G; Wei G; Chen Z; Zheng Y; Ma X; Siwko S; Chen JL; Liu M; Li D
J Immunol; 2015 Jul; 195(1):339-46. PubMed ID: 26026060
[TBL] [Abstract][Full Text] [Related]
7. Role of mTOR Inhibitors in Kidney Disease.
Kajiwara M; Masuda S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338360
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.
Arriola Apelo SI; Lamming DW
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):841-9. PubMed ID: 27208895
[TBL] [Abstract][Full Text] [Related]
9. GATOR1 complex: the common genetic actor in focal epilepsies.
Baldassari S; Licchetta L; Tinuper P; Bisulli F; Pippucci T
J Med Genet; 2016 Aug; 53(8):503-10. PubMed ID: 27208208
[TBL] [Abstract][Full Text] [Related]
10. mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition.
Limon JJ; So L; Jellbauer S; Chiu H; Corado J; Sykes SM; Raffatellu M; Fruman DA
Proc Natl Acad Sci U S A; 2014 Nov; 111(47):E5076-85. PubMed ID: 25385646
[TBL] [Abstract][Full Text] [Related]
11. Targeting mTOR Signaling Can Prevent the Progression of FSGS.
Zschiedrich S; Bork T; Liang W; Wanner N; Eulenbruch K; Munder S; Hartleben B; Kretz O; Gerber S; Simons M; Viau A; Burtin M; Wei C; Reiser J; Herbach N; Rastaldi MP; Cohen CD; Tharaux PL; Terzi F; Walz G; Gödel M; Huber TB
J Am Soc Nephrol; 2017 Jul; 28(7):2144-2157. PubMed ID: 28270414
[TBL] [Abstract][Full Text] [Related]
12. Next Generation Strategies for Geroprotection via mTORC1 Inhibition.
Dumas SN; Lamming DW
J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):14-23. PubMed ID: 30794726
[TBL] [Abstract][Full Text] [Related]
13. [mTORC1 and sirolimus: a link with fertility].
Tartarin P; Froment P
Med Sci (Paris); 2013 Feb; 29(2):200-5. PubMed ID: 23452608
[TBL] [Abstract][Full Text] [Related]
14. mTOR pathway inhibitors in cancer therapy: moving past rapamycin.
Wacheck V
Pharmacogenomics; 2010 Sep; 11(9):1189-91. PubMed ID: 20860456
[No Abstract] [Full Text] [Related]
15. Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer.
Nelson V; Altman JK; Platanias LC
Expert Opin Investig Drugs; 2013 Jun; 22(6):715-22. PubMed ID: 23544840
[TBL] [Abstract][Full Text] [Related]
16. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-derived secretory factor downregulates Semaphorin-3a in osteoblasts by activating mammalian target of rapamycin pathway.
Yamada D; Kawahara K; Ozaki M; Maeda T
Biosci Biotechnol Biochem; 2016 May; 80(5):942-4. PubMed ID: 26865270
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin treatment improves neuron viability in an in vitro model of stroke.
Fletcher L; Evans TM; Watts LT; Jimenez DF; Digicaylioglu M
PLoS One; 2013; 8(7):e68281. PubMed ID: 23861877
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin-sensitive mTORC1 signaling is involved in physiological primordial follicle activation in mouse ovary.
Tong Y; Li F; Lu Y; Cao Y; Gao J; Liu J
Mol Reprod Dev; 2013 Dec; 80(12):1018-34. PubMed ID: 24123525
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.
Wazir U; Newbold RF; Jiang WG; Sharma AK; Mokbel K
Oncol Rep; 2013 May; 29(5):1969-74. PubMed ID: 23503572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]